Advertisement

Topics

Alexion Appoints Francois Nader, M.D. to its Board of Directors

16:05 EST 8 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
—Former President and CEO of NPS Pharma Brings Strong Biotech Leadership and Rare Disease Expertise— Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Francois Nader, M.D., has been appointed to the Compan...

Other Sources for this Article

Alexion Pharmaceuticals, Inc.
Media:
Kim Diamond, 475-230-3775
Executive Director, Corporate Communications
or
Investors:
Elena Ridloff, CFA, 475-230-3601
Vice President, Investor Relations
or
Catherine Hu, 475-230-3599
Director, Investor Relations

NEXT ARTICLE

More From BioPortfolio on "Alexion Appoints Francois Nader, M.D. to its Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...